Test Story

By: NewsUSA

March 27, 2025 at 20:00 PM EDT

(NewsUSA) - For more details, including important safety information, on VenaSeal, visit: https://www.medtronic.com/breakfree.

Sources

Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5 Suppl):2S–48S. doi: 10.1016/j.jvs.2011.01.079.

Mayo Clinic: Varicose Veinshttps://www.mayoclinic.org/diseases-conditions/varicose-veins/symptoms-causes/syc-20350643

National Heart Lung and Blood Institute: Varicose Veins https://www.nhlbi.nih.gov/health/varicose-veins

Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015;61(4):985–994. doi: 10.1016/j.jvs.2014.11.071.

Proebstle T, Alm J, Dimitri S, et al. Three-year follow-up results of the prospective European multicenter cohort study on cyanoacrylate embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2021;9(2):329–334. doi: 10.1016/j.jvsv.2020.05.019.

Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2017;5(5):658–666. doi: 10.1016/j.jvsv.2017.03.016.

Symbol	Price	Change (%)
AMZN	248.50	-0.52 (-0.21%)
AAPL	266.43	+7.60 (2.94%)
AMD	258.12	+3.05 (1.20%)
BAC	54.32	+0.97 (1.82%)
GOOG	334.47	+3.89 (1.18%)
META	671.58	+9.09 (1.37%)
MSFT	411.22	+18.11 (4.61%)
NVDA	198.87	+2.36 (1.20%)
ORCL	169.81	+6.81 (4.18%)
TSLA	391.95	+27.75 (7.62%)

Symbol

Price

Change (%)

AMZN

248.50

-0.52 (-0.21%)

AAPL

266.43

+7.60 (2.94%)

AMD

258.12

+3.05 (1.20%)

BAC

54.32

+0.97 (1.82%)

GOOG

334.47

+3.89 (1.18%)

Test Story

More News

Recent Quotes

More ways to get to us

About Us

Contact the Lethbridge Herald